SCHEMBL25477641

SCHEMBL25477641

CC1CC2(CCN(CC3CN(C(C)C)C3)CC2)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24480556 0.81 ACHE (0.35) ACHE
SCHEMBL24475331 0.78 CYP2D6 (0.33)
SCHEMBL27012443 0.77 HRH3 (0.33)
SCHEMBL12827764 0.77 CYP2D6 (0.38)
SCHEMBL19768946 0.75 CHRM5 (0.46) ACHE
SCHEMBL26748268 0.75 ACHE (0.32) ACHE
SCHEMBL20046475 0.75 KCNH2 (0.34) ACHE
SCHEMBL13523623 0.75 CHRM5 (0.41) ACHE
SCHEMBL26950682 0.75 HRH3 (0.35)
SCHEMBL25664620 0.75 ACHE (0.61) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180432-A1 COMPOUND HAVING BTK KINASE DEGRADING ACTIVITY, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR Sichuan Haisco Pharmaceutical Co., Ltd. (CN) 2023-05-17 EP disclosed